文献速递间质性肺疾病

肺超声有望作为类风湿关节炎患者排除间质性肺病的筛查工具

Lung ultrasound is a promising screening tool to rule out interstitial lung disease in patients with rheumatoid arthritis.
PubMed 文献 · Respirology · 2024-02-18

结果显示肺超声敏感性90.6%、阴性预测值94.7%,筛查效能优于其他检查,提示其可作为低成本床旁工具用于排除RA-ILD。

要点

  • 肺超声以B线总和≥5为阳性,筛查RA-ILD的敏感性达90.6%。
  • 肺超声阴性预测值94.7%,适合用于排除RA-ILD。
  • 肺超声筛查效能优于胸部听诊、X线和肺功能检查。

核心结论

  • 肺超声是低成本床旁工具,具有高阴性预测值,可作为排除类风湿关节炎患者间质性肺病的有效筛查手段。

研究设计与样本

  • 以高分辨率CT为诊断间质性肺病的金标准,且在肺超声、胸片和肺功能检查后30天内完成。
  • 研究者对高分辨率CT结果和患者临床数据设盲。
  • 肺超声探查14个区域,以B线总和≥5判定为阳性。

主要发现

  • 肺超声诊断间质性肺病的敏感性为90.6%(95%CI:75.0%-98.0%),阴性预测值为94.7%(95%CI:85.4%-98.9%)。
  • 肺超声筛查间质性肺病的效能优于胸部听诊、胸片和肺功能检查。

关键数值与推荐

  • 肺超声阳性判定标准:14个探查区域B线总和≥5。
  • 肺超声筛查RA-ILD的敏感性90.6%(95%CI:75.0%-98.0%),阴性预测值94.7%(95%CI:85.4%-98.9%)。
  • RA-ILD患病率30.2%(95%CI:21.6%-39.9%)。

临床怎么用

  • 对类风湿关节炎患者,可考虑用肺超声作为床旁筛查工具,B线总和<5时有助于排除间质性肺病。
  • 肺超声阴性预测值高,适合用于低风险患者的排除性筛查,阳性者需进一步行高分辨率CT确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: It is still controversial how to screen for interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA). We aimed to evaluate the performance of lung ultrasound (LUS) as a screening tool for RA-ILD and to compare it with the performance of chest auscultation, chest x-ray and pulmonary function tests (PFTs). METHODS: Cross-sectional study of consecutive RA patients evaluated at a Rheumatology Clinic in Buenos Aires between January and December 2022. High-resolution computed tomography (HRCT) was the gold standard for diagnosing ILD and was performed within 30 days of the LUS, chest x-ray and PFTs. Investigators were blinded to HRCT results and patients' clinical data. LUS was performed by exploring 14 areas and was considered positive when the sum of B lines was ≥5. Performance for the diagnosis of ILD was reported for each diagnostic test. RESULTS: One hundred and six patients were included; 87 (82%) were women. Median age was 60.9 (±9.5) years-old. A total of 32 (30.2%, 95% CI: 21.6%-39.9%) had ILD. The sensitivity and negative predictive value of LUS were 90.6% (95% CI 75.0%-98.0%) and 94.7% (95% CI 85.4%-98.9%), respectively. LUS performance was superior to that of the other evaluated diagnostic tests for screening ILD. CONCLUSIONS: Given that the US is a low-cost point-of-care tool with a high negative predictive value, it is emerging as a valuable tool for ruling out ILD in patients with RA.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Otaola M, Paulin F, Rosemffet M, et al. Lung ultrasound is a promising screening tool to rule out interstitial lung disease in patients with rheumatoid arthritis. Respirology. 2024. PMID: 38369685. doi:10.1111/resp.14679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。